SlideShare une entreprise Scribd logo
1  sur  46
1
• Commonly encountered in Practice
• Diagnosis often is made incidentally
• The most common causes are primary
hyperparathyroidism and malignancy
• Diagnostic work-up includes measurement
of serum calcium, intact parathyroid
hormone (I-PTH), h/o any medications
• Hypercalcemic crisis is a life-threatening
emergency
2
• Most often asymptomatic – Incidental Dx
• Mild Hypercalcemia is asymptomatic
• Most important cause is hyper parathyroid
• DD is needed to decide the treatment
• Optimal step by step evaluation is a must.
3
• 98% of the body calcium is in the skeleton
• Only 2% is circulation and only half of this
is free calcium (ionized Ca++)
• This only is physiologically active
• The reminder 1% is bound to proteins
• Direct measurement of free Calcium ??
4
5
Parathyroid Hormone
1,25 DHC or Vitamin D3
Calcitonin
6
 Bone Resorption
 Intestinal Absorption
 Renal Excretion
(1,000 mg/day)
7
Hormone Effect Bone Gut Kidney
PTH  Ca  Po4
Increases
Osteoclasts
Indirect
via Vit. D
Ca reab
Po4 exr.
Vitamin D3  Ca  Po4
No direct
action
 Ca  Po4
absorption
No direct
effect
Calcitonin  Ca  Po4
Inhibits
Osteoclasts
No direct
effect
Ca & Po4
excretion
8
Corrected total calcium (mg%) =
[(Measured total calcium mg%) +
{(4.4 - measured albumin g%) x 0.8}]
Example:
[12.0 + {(4.4 – 2.4) x 0.8}] =
[ 12.0 + (2 x 0.8)] = 12.0 + 1.6 = 13.6
mg%
9
Calcitriol (Active)
Supplements
Vitamin D 2
10
Second hydroxylation in the Kidney at first position
1,25 dihydroxy Cholecalciferol Active Vitamin D (Calcitriol)
Successive hydroxylations of Cholecalciferol
25 hydroxylation in the Liver 25 hydroxy Cholecalciferol
Vitamin D is a steroid hormone
From dietary sources Action of Sunlight on skin
11
PTH
• 4 PT glands
• 84 AA
hormone
• Low Ca
stimulates it
Calcitriol (D)
• Active bone
formation
• Main effect is
on the Gut
• PTH  Vit. D
Calcitonin
• Para follicular
C of Thyroid
• 34 AA hormone
• On Kidney
12
13
Critical - > 14 mg %
Moderate - 12 to 14 mg %
Mild – 10.4 to 11.9 mg %
Normal – 8.5 to 10.3 mg %
14
Ca++
PTH
PTHrP Calcitriol
 Ca
at GIT
 Ca++
PTH
Vitamin D
Malignancy
Medicines
Endocrine
Genetic
15
• More than 90 percent of hypercalcemia cases are
Primary hyperparathyroidism and malignancy
• These conditions must be differentiated early
to provide optimal treatment & accurate prognosis
• Humoral hypercalcemia of malignancy implies a
very limited life expectancy — only a matter of
weeks
• Primary hyperparathyroidism has a benign course.
16
• Primary hyperparathyroidism
• Sporadic, familial, associated with
Multiple Endocrine Neoplasia (MEN I or II)
• Tertiary hyperparathyroidism
• Associated with chronic renal failure
• PTH  due to Vitamin D deficiency
17
• Vitamin D intoxication
• Iatrogenic Vitamin D injections
• Usually 25-hydroxyvitamin D2 in
over-the-counter supplements
• Granulomatous disease –
Sarcoidosis, Berylliosis, Tuberculosis
• Hodgkin’s lymphoma
18
• Humoral hypercalcemia of malignancy
(mediated by PTHrP) – common cause
• Solid tumors, especially lung, head and
neck squamous cancers
• Renal Cell Carcinoma (RCC)
• Local osteolysis (mediated by cytokines)
• Multiple Myeloma
• Breast cancer
19
• Thiazide diuretics (usually mild) - common
• Lithium for depressive illnesses
• Milk-alkali syndrome (calcium + antacids)
• Vitamin A intoxication (including
analogs used to treat acne)
20
• Hyperthyroidism
• Adrenal insufficiency
• Acromegaly
• Pheochromocytoma
21
• Familial hypocalciuric hypercalcemia (FHH)
mutated calcium-sensing receptor gene
• Immobilization, with high bone turnover
(e.g., Paget’s disease, bedridden child)
• Recovery phase of Rhabdomyolysis
22
• CNS
• GIT
• SKELETON
• KIDNEY
STONES BONES
GROANS
MOANS
23
Renal “stones”
• Nephrolithiasis
• Nephrogenic Diabetes Insipidus
• Dehydration
• Nephrocalcinosis
24
Skeleton “bones”
• Bone pains
• Arthritis
• Osteoporosis
• Osteitis fibrosa cystica in HPTH
25
Abdominal “Moans”
• Nausea, vomiting
• Severe anorexia, weight loss
• Constipation (not relieved by Rx.)
• Abdominal pain (vague and diffuse)
• Pancreatitis
• Peptic ulcer disease
26
Psychological “Groans”
• Impaired concentration
• Impaired memory, Depression
• Confusion, stupor, coma
• Lethargy and severe fatigue
• Extreme muscle weakness
• Corneal calcification (band keratopathy)
27
Cardiovascular
• Hypertension, Increased risk of CHD
• ECG changes of shortened QT interval, PR
prolonged, QRS widened, ST ,
Bradycardia
• Cardiac arrhythmias; Vascular calcification
Others
• Itching (Generalized Pruritus)
• Keratitis, conjunctivitis 28
29
? Suspect
 Calcium
Serum
Calcium
8.5 to 10.3
> 10.3 mg %
< 8.0 mg %
Hypocalcemia
Normal calcium
Medications
> 10.3 mg% I-PTH
High/Normal Pri PTH
Suppressed
Vit D Toxicity
Milk Alkali
Cancers/
Lymphoma
Suppressed PTHrP
30
PTHrP
Low or
Normal
Low or
Normal
1, 25 Vit. D
If Low
Cancer
If High
Lymphoma
High
24 hr. urine
calcium
Low – FHH
N or 
Sestamibi
31
Endocrine
32
33
• Increased screening for serum Ca++ and
• Wider availability of I-PTH assay
• 80% of cases single parathyroid adenoma
• Usually benign adenoma or hyperplasia
• Rarely parathyroid cancer
• High PTH in the setting of hypercalcemia
• Slowly progressive – Sestamibi N-scan
• 25% require surgery – RLN paralysis
34
64 yrs male - “hyper parathyroid storm”
with a serum calcium level of 16.4 mg%
• Serum calcium level > 12 mg % at any time
• Episodes of hyper parathyroid crisis
• Marked hypercalciuria (urinary Ca++ > 400 mg /day)
• Nephrolithiasis; Impaired renal function
• Osteitis fibrosa cystica – Thinning of cortical bone
• Reduced bone density by DEXA scan (Z score < 2)
• Classic neuromuscular symptoms, Proximal muscle
weakness and atrophy, Hyper reflexia and ataxia
• Age younger than 50 years
35
36
• 25 OH - Vitamin D2 is the supplemental Vit D
• Level of 25 OH – Vitamin D3 is to be measured
• Macrophages in the granulomas, lymphomas
cause extra renal conversion of 25 OH form to
the1,25 hydroxy derivative –the active Calcitriol
• PTH levels are suppressed; Calcitriol levels 
• Stop the offending use of Vitamin D
• Glucocorticoids – for over one month or more
• Manage hypercalcemia vigorously
37
• Most commonly mediated by systemic PTHrP
• Humoral Hypercalcemia of malignancy
• PTHrP mimics the bone & renal effects of PTH
• Normal Calcitriol and suppressed PTH levels
• Excessive bone lysis due to primary or bone
secondaries can cause hypercalcemia
• MM and metastatic Br Ca present in this way.
• In Osteolytic hypercalcemia, SAP is markedly 
• Hodgkin’s lymphoma –  production of Calcitriol
• Thiazide diuretics increase renal calcium
resorption and cause mild hypercalcemia
• Resolves after discontinuing the drug
• Thiazide unmasks hyperparathyroidism
• Milk–alkali syndrome – Ca + Antacids
• Lithium –  the set point for PTH 
• Excess Vitamin A -  bone resorption and
causes hypercalcemia.
38
• FHH – Familial Hypocalciuric Hypercalcemia
• AD – 100% penetrance – Ca-R gene mutation
• Moderate hypercalcemia with normal/  PTH
• 24 hour urinary calcium is very low
• No benefit from parathyroidectomy
• High bone turnover in Paget’s disease or
prolonged immobilization
• Recovery phase of Rhabdomyolysis
39
• Ca <12 but > 10.3 mg% – no appreciable
clinical benefit – they need evaluation
• Any patient with Serum Ca > 12 mg%
should be aggressively treated
• Ca > 14 mg% is Hypercalcemic crisis
• Always correct the Ca value for Sr
Albumin
40
I.V. Saline
Hydration
& Diuresis
Gluco-
Corticoids
Bisphos-
phonates
Calcitonin
I.M/S.C.
41
• Vigorous I.V. Nacl Diuresis – N Saline
• Adequate hydration – urine out put must be
maintained 200 ml/hour = 5 L /day
• The safest and most effective treatment of
Hypercalcemic crisis is saline rehydration
• Once the urine out put is maintained – give I.V.
Furosemide – a loop diuretic in low doses of 10
to 20 mg
• ERT - might be beneficial in PMW – new RCT
42
• In severe hypercalcemia refractory to
saline diuresis
• Calcitonin (Zycalcit, Miacalcin) 6 -8 U/kg
IM/SC (400 i.u) given every six hours.
• This treatment has a rapid onset but short
duration of effect
• Patients develop tolerance to the calcium-
lowering effect of Calcitonin.
43
• Zoledronic acid (Zometa) - 4 mg IV diluted in
100 ml of N Saline - over at least 15’ once a
M
• Pamindronate (Pamidria) - 60 mg IV infusion
over 4 h initial – repeated after a month
• Etidronate (Didronel) - 7.5 mg/kg IV over 4 h
daily for 3-7 d; dilute in at least 250 ml of
sterile N Saline
• They inhibit bone resorption, inhibit the
Osteoclastic activity. 44
• Dialysis for refractory Hypercalcemic crisis
• Parathyroidectomy for adenomas
• Rx. of the underlying cause – Eliminate drugs
• Plicamycin (Mithracin) 25 mcg/kg/d IV for 4 d
• Gallium nitrate (Ganite) 100 mg/m2/d IV for 5
days in 1 L of NS or 5% Dextrose
• Cinacalcet (Sensipar) - 30 mg PO od –
(increases sensitivity of calcium sensing
receptor) 45
• Hypercalcemia is often asymptomatic
• Screen all suspected by doing Sr Calcium
• If elevated, do I-PTH and follow algorithm
• 90% Hyperparathyroidism and malignancy
• Vitamin D toxicity is an important cause
• Thiazide diuretics common cause, Vitamin A
• Adequate hydration - N Saline + Furosemide
• Calcitonin + Zoledronic acid main stay of Rx.
46

Contenu connexe

Similaire à Hypercalcemia.ppt

Disorders of parathyroid gland
Disorders of parathyroid glandDisorders of parathyroid gland
Disorders of parathyroid gland
eram sid
 
Approach to Hypercalcemia
Approach to HypercalcemiaApproach to Hypercalcemia
Approach to Hypercalcemia
Raviraj Menon
 

Similaire à Hypercalcemia.ppt (20)

Calcium,magnesium,phosphate and chloride imbalances
Calcium,magnesium,phosphate and chloride imbalances Calcium,magnesium,phosphate and chloride imbalances
Calcium,magnesium,phosphate and chloride imbalances
 
Calcium,magnesium,phosphate and chloride imbalances
Calcium,magnesium,phosphate and chloride imbalances Calcium,magnesium,phosphate and chloride imbalances
Calcium,magnesium,phosphate and chloride imbalances
 
disorders-of-the-parathyroid-glands
disorders-of-the-parathyroid-glandsdisorders-of-the-parathyroid-glands
disorders-of-the-parathyroid-glands
 
Hpercalcemia & its Management
Hpercalcemia & its ManagementHpercalcemia & its Management
Hpercalcemia & its Management
 
Disorders of Parathyroid Gland
Disorders of Parathyroid GlandDisorders of Parathyroid Gland
Disorders of Parathyroid Gland
 
Hypercalcemia
HypercalcemiaHypercalcemia
Hypercalcemia
 
hyper and hypocalcemia.pptx
hyper and hypocalcemia.pptxhyper and hypocalcemia.pptx
hyper and hypocalcemia.pptx
 
Disorders of parathyroid gland
Disorders of parathyroid glandDisorders of parathyroid gland
Disorders of parathyroid gland
 
Endocrine disorders-Nursing Maseno.ppt11
Endocrine disorders-Nursing Maseno.ppt11Endocrine disorders-Nursing Maseno.ppt11
Endocrine disorders-Nursing Maseno.ppt11
 
How to approach hypercalcaemia?
How to approach hypercalcaemia?How to approach hypercalcaemia?
How to approach hypercalcaemia?
 
Disorders of calcium metabolism
Disorders of calcium metabolismDisorders of calcium metabolism
Disorders of calcium metabolism
 
Drugs affecting calcium balance
Drugs affecting calcium balanceDrugs affecting calcium balance
Drugs affecting calcium balance
 
Approach to Hypercalcemia
Approach to HypercalcemiaApproach to Hypercalcemia
Approach to Hypercalcemia
 
Magnesium metabolism
Magnesium metabolism Magnesium metabolism
Magnesium metabolism
 
Testing parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptxTesting parathyroid hormone disorders.pptx
Testing parathyroid hormone disorders.pptx
 
CALCIUM REGULATION.pptx
CALCIUM REGULATION.pptxCALCIUM REGULATION.pptx
CALCIUM REGULATION.pptx
 
parathyroid disorder
parathyroid disorderparathyroid disorder
parathyroid disorder
 
Hyper and hypocalcemia
Hyper and hypocalcemiaHyper and hypocalcemia
Hyper and hypocalcemia
 
Complications of ESRD
Complications of ESRDComplications of ESRD
Complications of ESRD
 
Paraneoplastic syndromes Part I
Paraneoplastic syndromes Part IParaneoplastic syndromes Part I
Paraneoplastic syndromes Part I
 

Plus de pradeepsingh855

Plus de pradeepsingh855 (20)

Rheumatic Heart Disease.pptttttttttttttt
Rheumatic Heart Disease.ppttttttttttttttRheumatic Heart Disease.pptttttttttttttt
Rheumatic Heart Disease.pptttttttttttttt
 
PresentationCCF.pptttttttttttttttttttttt
PresentationCCF.ppttttttttttttttttttttttPresentationCCF.pptttttttttttttttttttttt
PresentationCCF.pptttttttttttttttttttttt
 
VHD.pptttttttttttttttttttttttttttttttttt
VHD.ppttttttttttttttttttttttttttttttttttVHD.pptttttttttttttttttttttttttttttttttt
VHD.pptttttttttttttttttttttttttttttttttt
 
DM.pptx
DM.pptxDM.pptx
DM.pptx
 
TYPES OF STROKE.pptx
TYPES OF STROKE.pptxTYPES OF STROKE.pptx
TYPES OF STROKE.pptx
 
antifungal.pptx
antifungal.pptxantifungal.pptx
antifungal.pptx
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
ulcerative colities.pptx
ulcerative colities.pptxulcerative colities.pptx
ulcerative colities.pptx
 
tissues.pptx
tissues.pptxtissues.pptx
tissues.pptx
 
cell.pptx
cell.pptxcell.pptx
cell.pptx
 
Parkinsons diseases.pptx
Parkinsons diseases.pptxParkinsons diseases.pptx
Parkinsons diseases.pptx
 
Guillain-Barre syndrome.pptx
Guillain-Barre syndrome.pptxGuillain-Barre syndrome.pptx
Guillain-Barre syndrome.pptx
 
Glioma.pptx
Glioma.pptxGlioma.pptx
Glioma.pptx
 
spinal cord injury.pptx
spinal cord injury.pptxspinal cord injury.pptx
spinal cord injury.pptx
 
spinal cord injury ppt.pptx
spinal cord injury ppt.pptxspinal cord injury ppt.pptx
spinal cord injury ppt.pptx
 
NAUSEA AND VOMITING.pptx
NAUSEA AND VOMITING.pptxNAUSEA AND VOMITING.pptx
NAUSEA AND VOMITING.pptx
 
Shock.ppt
Shock.pptShock.ppt
Shock.ppt
 
hepatitis.pptx
hepatitis.pptxhepatitis.pptx
hepatitis.pptx
 
peptic ulcer.pptx
peptic ulcer.pptxpeptic ulcer.pptx
peptic ulcer.pptx
 
cirrhosis of liver.pptx
cirrhosis of liver.pptxcirrhosis of liver.pptx
cirrhosis of liver.pptx
 

Dernier

Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 

Dernier (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

Hypercalcemia.ppt

  • 1. 1
  • 2. • Commonly encountered in Practice • Diagnosis often is made incidentally • The most common causes are primary hyperparathyroidism and malignancy • Diagnostic work-up includes measurement of serum calcium, intact parathyroid hormone (I-PTH), h/o any medications • Hypercalcemic crisis is a life-threatening emergency 2
  • 3. • Most often asymptomatic – Incidental Dx • Mild Hypercalcemia is asymptomatic • Most important cause is hyper parathyroid • DD is needed to decide the treatment • Optimal step by step evaluation is a must. 3
  • 4. • 98% of the body calcium is in the skeleton • Only 2% is circulation and only half of this is free calcium (ionized Ca++) • This only is physiologically active • The reminder 1% is bound to proteins • Direct measurement of free Calcium ?? 4
  • 5. 5 Parathyroid Hormone 1,25 DHC or Vitamin D3 Calcitonin
  • 6. 6  Bone Resorption  Intestinal Absorption  Renal Excretion
  • 8. Hormone Effect Bone Gut Kidney PTH  Ca  Po4 Increases Osteoclasts Indirect via Vit. D Ca reab Po4 exr. Vitamin D3  Ca  Po4 No direct action  Ca  Po4 absorption No direct effect Calcitonin  Ca  Po4 Inhibits Osteoclasts No direct effect Ca & Po4 excretion 8
  • 9. Corrected total calcium (mg%) = [(Measured total calcium mg%) + {(4.4 - measured albumin g%) x 0.8}] Example: [12.0 + {(4.4 – 2.4) x 0.8}] = [ 12.0 + (2 x 0.8)] = 12.0 + 1.6 = 13.6 mg% 9
  • 11. Second hydroxylation in the Kidney at first position 1,25 dihydroxy Cholecalciferol Active Vitamin D (Calcitriol) Successive hydroxylations of Cholecalciferol 25 hydroxylation in the Liver 25 hydroxy Cholecalciferol Vitamin D is a steroid hormone From dietary sources Action of Sunlight on skin 11
  • 12. PTH • 4 PT glands • 84 AA hormone • Low Ca stimulates it Calcitriol (D) • Active bone formation • Main effect is on the Gut • PTH  Vit. D Calcitonin • Para follicular C of Thyroid • 34 AA hormone • On Kidney 12
  • 13. 13 Critical - > 14 mg % Moderate - 12 to 14 mg % Mild – 10.4 to 11.9 mg % Normal – 8.5 to 10.3 mg %
  • 16. • More than 90 percent of hypercalcemia cases are Primary hyperparathyroidism and malignancy • These conditions must be differentiated early to provide optimal treatment & accurate prognosis • Humoral hypercalcemia of malignancy implies a very limited life expectancy — only a matter of weeks • Primary hyperparathyroidism has a benign course. 16
  • 17. • Primary hyperparathyroidism • Sporadic, familial, associated with Multiple Endocrine Neoplasia (MEN I or II) • Tertiary hyperparathyroidism • Associated with chronic renal failure • PTH  due to Vitamin D deficiency 17
  • 18. • Vitamin D intoxication • Iatrogenic Vitamin D injections • Usually 25-hydroxyvitamin D2 in over-the-counter supplements • Granulomatous disease – Sarcoidosis, Berylliosis, Tuberculosis • Hodgkin’s lymphoma 18
  • 19. • Humoral hypercalcemia of malignancy (mediated by PTHrP) – common cause • Solid tumors, especially lung, head and neck squamous cancers • Renal Cell Carcinoma (RCC) • Local osteolysis (mediated by cytokines) • Multiple Myeloma • Breast cancer 19
  • 20. • Thiazide diuretics (usually mild) - common • Lithium for depressive illnesses • Milk-alkali syndrome (calcium + antacids) • Vitamin A intoxication (including analogs used to treat acne) 20
  • 21. • Hyperthyroidism • Adrenal insufficiency • Acromegaly • Pheochromocytoma 21
  • 22. • Familial hypocalciuric hypercalcemia (FHH) mutated calcium-sensing receptor gene • Immobilization, with high bone turnover (e.g., Paget’s disease, bedridden child) • Recovery phase of Rhabdomyolysis 22
  • 23. • CNS • GIT • SKELETON • KIDNEY STONES BONES GROANS MOANS 23
  • 24. Renal “stones” • Nephrolithiasis • Nephrogenic Diabetes Insipidus • Dehydration • Nephrocalcinosis 24
  • 25. Skeleton “bones” • Bone pains • Arthritis • Osteoporosis • Osteitis fibrosa cystica in HPTH 25
  • 26. Abdominal “Moans” • Nausea, vomiting • Severe anorexia, weight loss • Constipation (not relieved by Rx.) • Abdominal pain (vague and diffuse) • Pancreatitis • Peptic ulcer disease 26
  • 27. Psychological “Groans” • Impaired concentration • Impaired memory, Depression • Confusion, stupor, coma • Lethargy and severe fatigue • Extreme muscle weakness • Corneal calcification (band keratopathy) 27
  • 28. Cardiovascular • Hypertension, Increased risk of CHD • ECG changes of shortened QT interval, PR prolonged, QRS widened, ST , Bradycardia • Cardiac arrhythmias; Vascular calcification Others • Itching (Generalized Pruritus) • Keratitis, conjunctivitis 28
  • 29. 29 ? Suspect  Calcium Serum Calcium 8.5 to 10.3 > 10.3 mg % < 8.0 mg % Hypocalcemia Normal calcium
  • 30. Medications > 10.3 mg% I-PTH High/Normal Pri PTH Suppressed Vit D Toxicity Milk Alkali Cancers/ Lymphoma Suppressed PTHrP 30
  • 31. PTHrP Low or Normal Low or Normal 1, 25 Vit. D If Low Cancer If High Lymphoma High 24 hr. urine calcium Low – FHH N or  Sestamibi 31 Endocrine
  • 32. 32
  • 33. 33 • Increased screening for serum Ca++ and • Wider availability of I-PTH assay • 80% of cases single parathyroid adenoma • Usually benign adenoma or hyperplasia • Rarely parathyroid cancer • High PTH in the setting of hypercalcemia • Slowly progressive – Sestamibi N-scan • 25% require surgery – RLN paralysis
  • 34. 34 64 yrs male - “hyper parathyroid storm” with a serum calcium level of 16.4 mg%
  • 35. • Serum calcium level > 12 mg % at any time • Episodes of hyper parathyroid crisis • Marked hypercalciuria (urinary Ca++ > 400 mg /day) • Nephrolithiasis; Impaired renal function • Osteitis fibrosa cystica – Thinning of cortical bone • Reduced bone density by DEXA scan (Z score < 2) • Classic neuromuscular symptoms, Proximal muscle weakness and atrophy, Hyper reflexia and ataxia • Age younger than 50 years 35
  • 36. 36 • 25 OH - Vitamin D2 is the supplemental Vit D • Level of 25 OH – Vitamin D3 is to be measured • Macrophages in the granulomas, lymphomas cause extra renal conversion of 25 OH form to the1,25 hydroxy derivative –the active Calcitriol • PTH levels are suppressed; Calcitriol levels  • Stop the offending use of Vitamin D • Glucocorticoids – for over one month or more • Manage hypercalcemia vigorously
  • 37. 37 • Most commonly mediated by systemic PTHrP • Humoral Hypercalcemia of malignancy • PTHrP mimics the bone & renal effects of PTH • Normal Calcitriol and suppressed PTH levels • Excessive bone lysis due to primary or bone secondaries can cause hypercalcemia • MM and metastatic Br Ca present in this way. • In Osteolytic hypercalcemia, SAP is markedly  • Hodgkin’s lymphoma –  production of Calcitriol
  • 38. • Thiazide diuretics increase renal calcium resorption and cause mild hypercalcemia • Resolves after discontinuing the drug • Thiazide unmasks hyperparathyroidism • Milk–alkali syndrome – Ca + Antacids • Lithium –  the set point for PTH  • Excess Vitamin A -  bone resorption and causes hypercalcemia. 38
  • 39. • FHH – Familial Hypocalciuric Hypercalcemia • AD – 100% penetrance – Ca-R gene mutation • Moderate hypercalcemia with normal/  PTH • 24 hour urinary calcium is very low • No benefit from parathyroidectomy • High bone turnover in Paget’s disease or prolonged immobilization • Recovery phase of Rhabdomyolysis 39
  • 40. • Ca <12 but > 10.3 mg% – no appreciable clinical benefit – they need evaluation • Any patient with Serum Ca > 12 mg% should be aggressively treated • Ca > 14 mg% is Hypercalcemic crisis • Always correct the Ca value for Sr Albumin 40
  • 42. • Vigorous I.V. Nacl Diuresis – N Saline • Adequate hydration – urine out put must be maintained 200 ml/hour = 5 L /day • The safest and most effective treatment of Hypercalcemic crisis is saline rehydration • Once the urine out put is maintained – give I.V. Furosemide – a loop diuretic in low doses of 10 to 20 mg • ERT - might be beneficial in PMW – new RCT 42
  • 43. • In severe hypercalcemia refractory to saline diuresis • Calcitonin (Zycalcit, Miacalcin) 6 -8 U/kg IM/SC (400 i.u) given every six hours. • This treatment has a rapid onset but short duration of effect • Patients develop tolerance to the calcium- lowering effect of Calcitonin. 43
  • 44. • Zoledronic acid (Zometa) - 4 mg IV diluted in 100 ml of N Saline - over at least 15’ once a M • Pamindronate (Pamidria) - 60 mg IV infusion over 4 h initial – repeated after a month • Etidronate (Didronel) - 7.5 mg/kg IV over 4 h daily for 3-7 d; dilute in at least 250 ml of sterile N Saline • They inhibit bone resorption, inhibit the Osteoclastic activity. 44
  • 45. • Dialysis for refractory Hypercalcemic crisis • Parathyroidectomy for adenomas • Rx. of the underlying cause – Eliminate drugs • Plicamycin (Mithracin) 25 mcg/kg/d IV for 4 d • Gallium nitrate (Ganite) 100 mg/m2/d IV for 5 days in 1 L of NS or 5% Dextrose • Cinacalcet (Sensipar) - 30 mg PO od – (increases sensitivity of calcium sensing receptor) 45
  • 46. • Hypercalcemia is often asymptomatic • Screen all suspected by doing Sr Calcium • If elevated, do I-PTH and follow algorithm • 90% Hyperparathyroidism and malignancy • Vitamin D toxicity is an important cause • Thiazide diuretics common cause, Vitamin A • Adequate hydration - N Saline + Furosemide • Calcitonin + Zoledronic acid main stay of Rx. 46